Today: 20 May 2026
Nebius (NBIS) stock ticks up as AI names rebound — Rubin rollout and earnings are the next tests
9 January 2026
1 min read

Nebius (NBIS) stock ticks up as AI names rebound — Rubin rollout and earnings are the next tests

NEW YORK, Jan 9, 2026, 15:16 EST — Regular session

  • Nebius shares up 1.2% in afternoon trade after a sharp intraday swing
  • AI infrastructure names were broadly higher as chip stocks led Wall Street’s gains
  • Investors are watching the Nvidia Rubin timetable and Nebius’ next earnings update

Nebius Group N.V. shares were up 1.2% at $98.48 on Friday afternoon, paring earlier gains after the stock briefly climbed above $104. The Nasdaq-listed shares have ranged from $97.25 to $104.94 in the session.

The move came as U.S. stocks pushed higher, with the S&P 500 hitting a record high as chipmakers led broad gains after a weaker-than-expected jobs report, Reuters reported. “On the overall AI theme, investors are getting granular and picking the winners and losers in terms of sub-themes and individual names,” said Zachary Hill, head of portfolio management at Horizon Investments. Reuters

Other AI infrastructure plays were higher: Nvidia was up about 0.5%, CoreWeave gained about 3%, and Applied Digital jumped more than 17%.

Nebius has also been on traders’ screens since it said it will offer Nvidia’s Vera Rubin NVL72 platform in the U.S. and Europe from H2 2026 — the second half of the year. Chief executive Arkady Volozh said Nebius was “proud to be one of the first on the market” to offer Rubin GPUs. The company said Rubin would be deployed through its AI Cloud and “Token Factory,” a service aimed at AI inference — when a model generates output. Nebius

Nvidia announced Rubin at CES on Jan. 5 and said Rubin-based products would be available from partners in the second half of 2026. The chipmaker said its Vera Rubin NVL72 system combines 72 Rubin GPUs and 36 Vera CPUs.

Nebius, based in Amsterdam, has been building out data-center capacity after signing multi-billion-dollar contracts with Microsoft and Meta, Reuters reported in December. It competes with U.S. “hyperscalers” such as Amazon and Google — the giant cloud firms — while targeting 2.5 gigawatts of contracted power by end-2026, power agreements needed to run new data centers. Co-founder Roman Chernin told Reuters: “We should be ready (for when) the winter will come.” Reuters

But delivery schedules and funding still matter. Nebius has leaned on external financing, including convertible notes — debt that can turn into shares — and an equity sale to support growth, and any delay in GPU supply or power build-outs could crimp expansion plans.

On the chart, traders have been treating the $97 area as near-term support, with resistance near $105 after Friday’s spike. NBIS has traded between $18.31 and $141.10 over the past 52 weeks, a reminder of how quickly this one can move.

Next up is earnings: Nebius’ next report is estimated for Feb. 18, before the market opens, according to MarketBeat, with investors looking for updates on capacity and the Rubin timetable.

Stock Market Today

  • Trump's Truth Social Withdraws Bitcoin and Bitcoin-Ethereum ETF Applications Amid Market Pressure
    May 20, 2026, 7:22 AM EDT. Trump Media & Technology Group has withdrawn its applications for Bitcoin and Bitcoin-Ethereum exchange-traded funds (ETFs), citing a strategic shift to pursue a different regulatory framework under the Investment Company Act of 1940 ('40 Act) instead of the Securities Act of 1933 ('33 Act). Yorkville America, the investment advisor, highlighted that the '40 Act allows more flexible investment strategies. This move comes amid intense fee competition in the U.S. spot Bitcoin ETF market, valued at $57.4 billion since January 2024, following Morgan Stanley's MSBT launch, which offers a low 0.14% expense ratio. The withdrawal underscores heightened competition and evolving regulatory approaches in the crypto ETF space.

Latest articles

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

20 May 2026
InMed Pharmaceuticals shares fell 14.4% to $1.37 in early pre-market trading Wednesday, after surging 135% Tuesday on news of an all-stock merger with Mentari Therapeutics and a planned $290 million private placement. Pre-merger InMed shareholders are expected to own about 1.51% of the combined company, which will operate as Mentari Therapeutics and focus on migraine drug development.
Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

20 May 2026
Micware shares jumped 97.7% to $9.33 in premarket U.S. trading Wednesday, rebounding above last week’s $8 IPO price after closing Tuesday at $4.72. A new SEC filing showed Toyota owns 11.6% of Micware’s ordinary shares. The Japanese automotive software firm raised $22.8 million in its Nasdaq debut last week.
Dow edges up while Nasdaq falls as bond worries drag on

Futures Edge Higher Ahead of Nvidia Earnings as Wall Street Watches Key Report

20 May 2026
Nasdaq 100 futures rose 0.73% and S&P 500 futures gained 0.35% ahead of Wednesday’s open, with Nvidia set to report earnings after the close. Options markets priced in a 6.5% swing for Nvidia, equal to about $355 billion in market value. In premarket trading, Nvidia shares rose 1.84%, while Micron, Intel, and AMD also advanced. Fed minutes are due at 2:00 p.m. EDT.
Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14
Previous Story

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14

Applied Digital stock jumps again as AI data-center demand and hyperscaler talks drive the tape
Next Story

Applied Digital stock jumps again as AI data-center demand and hyperscaler talks drive the tape

Go toTop